OFIX übertreffen die 31 der letzten 40Schätzungen.
78%
Nächster Bericht
Datum des nächsten Berichts
23. Feb. 2026
Estimate forQ4 25(Revenue/ EPS)
$222.94M
/
-$0.31
Implizierte Änderung vonQ3 25(Revenue/ EPS)
+8.42%
/
-44.64%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+3.38%
/
-1650.00%
Orthofix Medical Inc. Common Stock (DE) earnings per share and revenue
On 04. Nov. 2025, OFIX reported earnings of -0.56 USD per share (EPS) for Q3 25, missing the estimate of -0.41 USD, resulting in a -37.42% surprise. Revenue reached 205.63 million, compared to an expected 204.01 million, with a 0.80% difference. The market reacted with a -7.41% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 222.94 million USD, implying an decrease of -44.64% EPS, and increase of 8.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
What were Orthofix Medical Inc. Common Stock (DE)'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Orthofix Medical Inc. Common Stock (DE) reported EPS of -$0.56, missing estimates by -37.42%, and revenue of $205.63M, 0.8% above expectations.
How did the market react to Orthofix Medical Inc. Common Stock (DE)'s Q3 2025 earnings?
The stock price moved down -7.41%, changed from $16.06 before the earnings release to $14.87 the day after.
When is Orthofix Medical Inc. Common Stock (DE) expected to report next?
The next earning report is scheduled for 23. Feb. 2026.
What are the forecasts for Orthofix Medical Inc. Common Stock (DE)'s next earnings report?
Based on 5
analysts, Orthofix Medical Inc. Common Stock (DE) is expected to report EPS of -$0.31 and revenue of $222.94M for Q4 2025.